ERBB2 and breast cancer: Furthermore, low SFN expression levels were associated with the decreased overall survival of breast cancer patients, specifically within the HER2-enriched human subtype (Fig. 5b; Supplementary Fig. 11c), most consistent with a loss-of-function, tumour suppressive role of SFN.